ArticleFrontiers in oncology2022

Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification.

Yijing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.